Mala Murthy - 04 Apr 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 04 Apr 2025
Net transactions value: -$51,012
Form type: 4
Filing time: 08 Apr 2025, 16:23:48 UTC
Previous filing: 21 Mar 2025
Next filing: 12 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+12,652	+11%		128,961	04 Apr 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	$51,012	-7,494	-5.8%	$6.81	121,467	07 Apr 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-12,652	-33%	$0.000000	25,305	04 Apr 2025	Common Stock	12,652		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.